An article published by the Heart Rhythm Society’s journal Heart Rhythm O2 concludes that Vektor’s Computational ECG Mapping System (vMap™) and protocol-based respiratory gating may help facilitate ...

SAN DIEGO--(BUSINESS WIRE)--Vektor Medical today announced its vMap ® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by ...

Research presented at AHA Scientific Sessions 2023 associates vMap’s use with significantly improved outcomes for unstable VT and surgical ablation of ventricular arrhythmias SAN DIEGO, November 10, ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...

Vektor Medical, the developer of the vMap AI-based system for mapping arrhythmias using a standard 12-lead ECG, has released a series of software enhancements to the non-invasive solution. The ...

The knowledge that recovering Covid-19 patients face an increased risk of cardiac arrhythmia(Opens in a new window) complications, is one factor contributing to the ...

Milestone Highlights Rapid Hospital Adoption and Clinical Demand for Arrhythmia Insights that Improve Outcomes and Reduce Procedure Time Vektor Medical today announced its vMap® system has been used ...

Milestone Highlights Rapid Hospital Adoption and Clinical Demand for Arrhythmia Insights that Improve Outcomes and Reduce Procedure Time vMap, developed with AI and designed to localize both focal and ...